(Q46501572)

English

Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial

scientific article published on 10 September 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Intravenous and oral levetiracetam in patients with a suspected primary brain tumor and symptomatic seizures undergoing neurosurgery: the HELLO trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

10

object named as

Michael Weller

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

Marcos Soares Tatagiba

8

object named as

Marcos Tatagiba

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

author name string

Oliver Bähr

1

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Mirjam Hermisson

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Sabine Rona

3

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Johannes Rieger

4

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Susanne Nussbaum

5

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Peter Körtvelyessy

6

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Kea Franz

7

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Volker Seifert

9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Joachim P Steinbach

11

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

publication date

10 September 2011

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

Acta Neurochirurgica

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

154

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

2

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

229-35; discussion 235

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

https://scigraph.springernature.com/pub.10.1007/s00701-011-1144-9

0 references

The pathogenesis of tumour associated epilepsy

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Factors influencing seizures in adult patients with supratentorial astrocytic tumors.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Safety and feasibility of switching from phenytoin to levetiracetam monotherapy for glioma-related seizure control following craniotomy: a randomized phase II pilot study

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Assessment of a dose-response relationship of levetiracetam.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Seizures in patients with glioma treated with phenytoin and levetiracetam

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Efficacy and tolerability of levetiracetam versus phenytoin after supratentorial neurosurgery

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

The course of seizure disorders in patients with malignant gliomas.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Valproate-induced thrombocytopenia: a prospective monotherapy study.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Clinically relevant drug interactions with antiepileptic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Single-dose bioavailability of levetiracetam intravenous infusion relative to oral tablets and multiple-dose pharmacokinetics and tolerability of levetiracetam intravenous infusion compared with placebo in healthy subjects.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Efficacy and safety of levetiracetam in patients with glioma: a clinical prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Brain tumor and seizures: pathophysiology and its implications for treatment revisited

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Seizures and brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

A prospective evaluation and literature review of levetiracetam use in patients with brain tumors and seizures

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Efficacy of anti-epileptic drugs in patients with gliomas and seizures.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Optimal seizure management in brain tumor patients

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Optimizing therapy of seizures in patients with brain tumors

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Interactions between antiepileptic and chemotherapeutic drugs

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Treating seizures in patients with brain tumors: Drug interactions between antiepileptic and chemotherapeutic agents

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Pharmacotherapy of epileptic seizures in glioma patients: who, when, why and how long?

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Perioperative levetiracetam for prevention of seizures in supratentorial brain tumor surgery.

1 reference

https://api.crossref.org/works/10.1007%2FS00701-011-1144-9

21 January 2018

Identifiers

10.1007/S00701-011-1144-9

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

22 December 2017

http://europepmc.org/abstract/MED/21909835

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46501572&oldid=2114484011"